Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LET-PKD: Tolvaptan in ADPKD
NCT02729662Phase 4Unknown
- Sponsor
- Kyorin University
- Start
- Oct 2016
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tolvaptan in autosomal dominant polycystic kidney disease (ADPKD), sponsored by Kyorin University. Status: unknown.
02
Drugs
tolvaptan
03
Conditions
autosomal dominant polycystic kidney disease (ADPKD)
Beyond the preview
Go deeper on NCT02729662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02729662.